PKNOX2 and ovarian carcinoma: LINC02489 interacts with PKNOX2 through the PTEN/mTOR axis to reduce the migration and invasion of chemotherapy-resistant SKOV3 cells, thereby increasing the sensitivity of ovarian cancer to paclitaxel [33].